nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—HTR1F—trigeminal nerve—head and neck cancer	0.142	0.234	CbGeAlD
Sertindole—CYP2D6—Hydroxyurea—head and neck cancer	0.0581	0.567	CbGbCtD
Sertindole—HTR1B—trigeminal nerve—head and neck cancer	0.058	0.096	CbGeAlD
Sertindole—HTR1D—trigeminal nerve—head and neck cancer	0.0562	0.093	CbGeAlD
Sertindole—HRH1—nose—head and neck cancer	0.0426	0.0705	CbGeAlD
Sertindole—HTR1B—cranial nerve—head and neck cancer	0.0413	0.0684	CbGeAlD
Sertindole—HTR1D—cranial nerve—head and neck cancer	0.04	0.0662	CbGeAlD
Sertindole—HTR2A—trigeminal nerve—head and neck cancer	0.0279	0.0462	CbGeAlD
Sertindole—CYP2D6—Vinblastine—head and neck cancer	0.0206	0.201	CbGbCtD
Sertindole—HTR2A—cranial nerve—head and neck cancer	0.0199	0.0329	CbGeAlD
Sertindole—CYP3A4—Vinblastine—head and neck cancer	0.0131	0.128	CbGbCtD
Sertindole—HTR1F—head—head and neck cancer	0.0123	0.0203	CbGeAlD
Sertindole—CYP3A4—Docetaxel—head and neck cancer	0.0108	0.105	CbGbCtD
Sertindole—HTR1E—head—head and neck cancer	0.0106	0.0176	CbGeAlD
Sertindole—ADRA1D—epithelium—head and neck cancer	0.0105	0.0174	CbGeAlD
Sertindole—DRD3—head—head and neck cancer	0.00866	0.0143	CbGeAlD
Sertindole—HTR6—head—head and neck cancer	0.00834	0.0138	CbGeAlD
Sertindole—HTR1D—connective tissue—head and neck cancer	0.00826	0.0137	CbGeAlD
Sertindole—ADRA1B—head—head and neck cancer	0.00666	0.011	CbGeAlD
Sertindole—ADRA1D—head—head and neck cancer	0.00651	0.0108	CbGeAlD
Sertindole—ADRA1A—epithelium—head and neck cancer	0.00603	0.00997	CbGeAlD
Sertindole—HTR2A—neck—head and neck cancer	0.00572	0.00947	CbGeAlD
Sertindole—HTR1B—head—head and neck cancer	0.00503	0.00832	CbGeAlD
Sertindole—HRH1—connective tissue—head and neck cancer	0.00491	0.00813	CbGeAlD
Sertindole—HTR1D—head—head and neck cancer	0.00487	0.00805	CbGeAlD
Sertindole—ADRA2A—connective tissue—head and neck cancer	0.00483	0.00799	CbGeAlD
Sertindole—HTR2C—head—head and neck cancer	0.00482	0.00798	CbGeAlD
Sertindole—HRH1—epithelium—head and neck cancer	0.00466	0.00772	CbGeAlD
Sertindole—ADRA1A—lymphoid tissue—head and neck cancer	0.00464	0.00768	CbGeAlD
Sertindole—SLC6A4—head—head and neck cancer	0.00457	0.00756	CbGeAlD
Sertindole—Haloperidol—CYP1A1—head and neck cancer	0.00413	1	CrCbGaD
Sertindole—HRH1—trachea—head and neck cancer	0.00412	0.00683	CbGeAlD
Sertindole—HTR2A—connective tissue—head and neck cancer	0.0041	0.00679	CbGeAlD
Sertindole—HTR1A—head—head and neck cancer	0.00406	0.00671	CbGeAlD
Sertindole—ADRA2A—trachea—head and neck cancer	0.00405	0.0067	CbGeAlD
Sertindole—HTR2A—epithelium—head and neck cancer	0.0039	0.00645	CbGeAlD
Sertindole—ADRA1A—head—head and neck cancer	0.00374	0.00619	CbGeAlD
Sertindole—DRD2—head—head and neck cancer	0.00367	0.00607	CbGeAlD
Sertindole—KCNH2—head—head and neck cancer	0.00361	0.00598	CbGeAlD
Sertindole—HTR2A—trachea—head and neck cancer	0.00344	0.0057	CbGeAlD
Sertindole—ADRA2A—thyroid gland—head and neck cancer	0.0032	0.0053	CbGeAlD
Sertindole—HRH1—head—head and neck cancer	0.00289	0.00479	CbGeAlD
Sertindole—ADRA2A—head—head and neck cancer	0.00284	0.00471	CbGeAlD
Sertindole—KCNH2—lymph node—head and neck cancer	0.00253	0.00418	CbGeAlD
Sertindole—HTR2A—head—head and neck cancer	0.00242	0.004	CbGeAlD
Sertindole—CYP2D6—head—head and neck cancer	0.0022	0.00364	CbGeAlD
Sertindole—HRH1—lymph node—head and neck cancer	0.00203	0.00335	CbGeAlD
Sertindole—ADRA2A—lymph node—head and neck cancer	0.00199	0.00329	CbGeAlD
Sertindole—HTR6—Signaling by GPCR—AKT1—head and neck cancer	6.96e-05	0.000241	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	6.95e-05	0.00024	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—PTEN—head and neck cancer	6.93e-05	0.00024	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	6.92e-05	0.000239	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	6.92e-05	0.000239	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	6.91e-05	0.000239	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	6.91e-05	0.000239	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	6.9e-05	0.000239	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—PTEN—head and neck cancer	6.82e-05	0.000236	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—HRAS—head and neck cancer	6.82e-05	0.000236	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—AKT1—head and neck cancer	6.76e-05	0.000234	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	6.71e-05	0.000232	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—HRAS—head and neck cancer	6.7e-05	0.000232	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—HRAS—head and neck cancer	6.7e-05	0.000232	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—TYMS—head and neck cancer	6.66e-05	0.00023	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—AKT1—head and neck cancer	6.66e-05	0.00023	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	6.61e-05	0.000229	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	6.6e-05	0.000228	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	6.59e-05	0.000228	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—GSTM1—head and neck cancer	6.58e-05	0.000228	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—AKT1—head and neck cancer	6.51e-05	0.000225	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—AKT1—head and neck cancer	6.51e-05	0.000225	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	6.46e-05	0.000224	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—VEGFA—head and neck cancer	6.44e-05	0.000223	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL2—head and neck cancer	6.44e-05	0.000223	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL2—head and neck cancer	6.44e-05	0.000223	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	6.41e-05	0.000222	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	6.4e-05	0.000221	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	6.38e-05	0.000221	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—STAT3—head and neck cancer	6.38e-05	0.000221	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—AKT1—head and neck cancer	6.38e-05	0.000221	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—EGFR—head and neck cancer	6.38e-05	0.000221	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—STAT3—head and neck cancer	6.33e-05	0.000219	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	6.31e-05	0.000218	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—GPX1—head and neck cancer	6.3e-05	0.000218	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	6.28e-05	0.000217	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—CCND1—head and neck cancer	6.28e-05	0.000217	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—CCND1—head and neck cancer	6.28e-05	0.000217	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	6.28e-05	0.000217	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	6.27e-05	0.000217	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	6.27e-05	0.000217	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—EGFR—head and neck cancer	6.26e-05	0.000217	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—VEGFA—head and neck cancer	6.26e-05	0.000217	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—CYP1A1—head and neck cancer	6.24e-05	0.000216	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—STAT3—head and neck cancer	6.2e-05	0.000214	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—VEGFA—head and neck cancer	6.16e-05	0.000213	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	6.15e-05	0.000213	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	6.15e-05	0.000213	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—STAT3—head and neck cancer	6.1e-05	0.000211	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	6.1e-05	0.000211	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—MAPK3—head and neck cancer	6.1e-05	0.000211	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—PTEN—head and neck cancer	6.06e-05	0.00021	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—PTEN—head and neck cancer	6.06e-05	0.00021	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	6.05e-05	0.000209	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—AKT1—head and neck cancer	6.02e-05	0.000208	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	6.01e-05	0.000208	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	6e-05	0.000208	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	6e-05	0.000208	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	5.99e-05	0.000207	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—MAPK3—head and neck cancer	5.92e-05	0.000205	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—AKT1—head and neck cancer	5.91e-05	0.000205	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—AKT1—head and neck cancer	5.91e-05	0.000205	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.88e-05	0.000203	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	5.84e-05	0.000202	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—MAPK3—head and neck cancer	5.83e-05	0.000202	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	5.81e-05	0.000201	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—MAPK1—head and neck cancer	5.8e-05	0.000201	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—EGFR—head and neck cancer	5.8e-05	0.000201	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	5.76e-05	0.000199	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—EGFR—head and neck cancer	5.76e-05	0.000199	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	5.71e-05	0.000198	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	5.71e-05	0.000198	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PTGS2—head and neck cancer	5.69e-05	0.000197	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	5.67e-05	0.000196	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	5.64e-05	0.000195	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	5.64e-05	0.000195	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—EGFR—head and neck cancer	5.64e-05	0.000195	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL2—head and neck cancer	5.61e-05	0.000194	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL2—head and neck cancer	5.58e-05	0.000193	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	5.56e-05	0.000192	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—MAPK1—head and neck cancer	5.55e-05	0.000192	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—EGFR—head and neck cancer	5.55e-05	0.000192	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	5.54e-05	0.000192	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	5.47e-05	0.000189	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—VEGFA—head and neck cancer	5.47e-05	0.000189	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—CCND1—head and neck cancer	5.47e-05	0.000189	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.46e-05	0.000189	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	5.45e-05	0.000188	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—CCND1—head and neck cancer	5.44e-05	0.000188	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	5.44e-05	0.000188	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	5.42e-05	0.000187	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—STAT3—head and neck cancer	5.42e-05	0.000187	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	5.4e-05	0.000187	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL2—head and neck cancer	5.35e-05	0.000185	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	5.34e-05	0.000185	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PTEN—head and neck cancer	5.28e-05	0.000183	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PTEN—head and neck cancer	5.25e-05	0.000182	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	5.21e-05	0.00018	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	5.18e-05	0.000179	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MAPK3—head and neck cancer	5.18e-05	0.000179	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	5.15e-05	0.000178	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	5.13e-05	0.000177	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—HRAS—head and neck cancer	5.12e-05	0.000177	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	5.04e-05	0.000174	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	5.03e-05	0.000174	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—HRAS—head and neck cancer	5.03e-05	0.000174	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	5.03e-05	0.000174	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	5e-05	0.000173	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	4.98e-05	0.000172	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PTEN—head and neck cancer	4.96e-05	0.000172	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	4.96e-05	0.000171	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	4.94e-05	0.000171	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL2—head and neck cancer	4.93e-05	0.00017	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	4.93e-05	0.00017	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MAPK1—head and neck cancer	4.93e-05	0.00017	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	4.93e-05	0.00017	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—EGFR—head and neck cancer	4.93e-05	0.00017	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	4.91e-05	0.00017	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	4.9e-05	0.00017	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	4.89e-05	0.000169	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	4.89e-05	0.000169	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TP53—head and neck cancer	4.87e-05	0.000168	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL2—head and neck cancer	4.85e-05	0.000168	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL2—head and neck cancer	4.84e-05	0.000167	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TP53—head and neck cancer	4.83e-05	0.000167	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	4.81e-05	0.000166	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CCND1—head and neck cancer	4.8e-05	0.000166	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	4.8e-05	0.000166	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	4.77e-05	0.000165	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL2—head and neck cancer	4.75e-05	0.000164	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	4.75e-05	0.000164	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TP53—head and neck cancer	4.73e-05	0.000164	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CCND1—head and neck cancer	4.73e-05	0.000164	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—STAT3—head and neck cancer	4.72e-05	0.000163	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CCND1—head and neck cancer	4.72e-05	0.000163	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—STAT3—head and neck cancer	4.7e-05	0.000163	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—HRAS—head and neck cancer	4.66e-05	0.000161	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TP53—head and neck cancer	4.66e-05	0.000161	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PTEN—head and neck cancer	4.64e-05	0.00016	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	4.63e-05	0.00016	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—HRAS—head and neck cancer	4.62e-05	0.00016	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	4.59e-05	0.000159	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PTEN—head and neck cancer	4.56e-05	0.000158	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PTEN—head and neck cancer	4.55e-05	0.000157	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	4.54e-05	0.000157	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—HRAS—head and neck cancer	4.53e-05	0.000157	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—AKT1—head and neck cancer	4.52e-05	0.000156	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	4.51e-05	0.000156	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	4.5e-05	0.000156	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	4.49e-05	0.000155	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	4.47e-05	0.000155	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	4.46e-05	0.000154	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—HRAS—head and neck cancer	4.45e-05	0.000154	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	4.45e-05	0.000154	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—AKT1—head and neck cancer	4.44e-05	0.000154	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL2—head and neck cancer	4.41e-05	0.000153	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	4.36e-05	0.000151	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—TYMS—head and neck cancer	4.35e-05	0.000151	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.3e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	4.3e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	4.3e-05	0.000149	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	4.29e-05	0.000149	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—EGFR—head and neck cancer	4.29e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	4.28e-05	0.000148	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	4.28e-05	0.000148	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	4.27e-05	0.000148	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—EGFR—head and neck cancer	4.27e-05	0.000148	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—VEGFA—head and neck cancer	4.19e-05	0.000145	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	4.15e-05	0.000144	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—STAT3—head and neck cancer	4.15e-05	0.000143	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TP53—head and neck cancer	4.14e-05	0.000143	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TP53—head and neck cancer	4.14e-05	0.000143	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	4.12e-05	0.000143	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GPX1—head and neck cancer	4.12e-05	0.000143	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—VEGFA—head and neck cancer	4.11e-05	0.000142	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—AKT1—head and neck cancer	4.11e-05	0.000142	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	4.09e-05	0.000141	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	4.09e-05	0.000141	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—AKT1—head and neck cancer	4.08e-05	0.000141	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—STAT3—head and neck cancer	4.08e-05	0.000141	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.08e-05	0.000141	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—STAT3—head and neck cancer	4.07e-05	0.000141	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	4.05e-05	0.00014	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	4.04e-05	0.00014	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	4e-05	0.000138	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—AKT1—head and neck cancer	4e-05	0.000138	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK3—head and neck cancer	3.96e-05	0.000137	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—HRAS—head and neck cancer	3.96e-05	0.000137	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	3.96e-05	0.000137	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—AKT1—head and neck cancer	3.93e-05	0.000136	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	3.9e-05	0.000135	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK3—head and neck cancer	3.89e-05	0.000135	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	3.82e-05	0.000132	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK1—head and neck cancer	3.77e-05	0.00013	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—EGFR—head and neck cancer	3.77e-05	0.00013	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	3.75e-05	0.00013	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	3.73e-05	0.000129	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	3.71e-05	0.000128	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	3.71e-05	0.000128	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.71e-05	0.000128	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—EGFR—head and neck cancer	3.71e-05	0.000128	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	3.71e-05	0.000128	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK1—head and neck cancer	3.7e-05	0.000128	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—EGFR—head and neck cancer	3.7e-05	0.000128	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	3.63e-05	0.000126	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	3.63e-05	0.000126	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TP53—head and neck cancer	3.6e-05	0.000125	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TP53—head and neck cancer	3.59e-05	0.000124	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	3.55e-05	0.000123	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	3.55e-05	0.000123	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PIK3CA—head and neck cancer	3.5e-05	0.000121	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	3.49e-05	0.000121	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—AKT1—head and neck cancer	3.49e-05	0.000121	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HRAS—head and neck cancer	3.45e-05	0.000119	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TP53—head and neck cancer	3.43e-05	0.000119	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HRAS—head and neck cancer	3.43e-05	0.000119	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	3.37e-05	0.000117	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	3.37e-05	0.000117	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	3.28e-05	0.000114	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	3.27e-05	0.000113	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PTEN—head and neck cancer	3.23e-05	0.000112	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	3.22e-05	0.000111	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	3.21e-05	0.000111	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TP53—head and neck cancer	3.16e-05	0.000109	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	3.15e-05	0.000109	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TP53—head and neck cancer	3.11e-05	0.000108	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TP53—head and neck cancer	3.11e-05	0.000107	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TP53—head and neck cancer	3.05e-05	0.000105	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—AKT1—head and neck cancer	3.04e-05	0.000105	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—AKT1—head and neck cancer	3.03e-05	0.000105	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HRAS—head and neck cancer	3.03e-05	0.000105	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HRAS—head and neck cancer	2.98e-05	0.000103	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HRAS—head and neck cancer	2.97e-05	0.000103	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	2.93e-05	0.000101	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	2.92e-05	0.000101	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	2.9e-05	0.0001	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—AKT1—head and neck cancer	2.86e-05	9.9e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TP53—head and neck cancer	2.83e-05	9.8e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	2.71e-05	9.37e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—AKT1—head and neck cancer	2.67e-05	9.24e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—AKT1—head and neck cancer	2.63e-05	9.1e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—AKT1—head and neck cancer	2.62e-05	9.08e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	2.57e-05	8.91e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.43e-05	8.39e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	2.39e-05	8.28e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.28e-05	7.89e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PTEN—head and neck cancer	2.12e-05	7.32e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—AKT1—head and neck cancer	1.86e-05	6.45e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.49e-05	5.16e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—AKT1—head and neck cancer	1.22e-05	4.22e-05	CbGpPWpGaD
